How many Tropical Smoothie Cafe locations are in Georgia?
A locally-based chain with locations all over the nation was recently ranked as one of USA Today's 10Best restaurants for quick, healthy food. Editors and experts nominated their favorites, then those were voted on by readers. The 10 crowned boast quick, healthy food offering customizable, health-conscious menus, efficient service, and affordable options.
What is Georgia's best restaurant for quick, healthy food?
The only Georgia restaurant to make the list is the Tropical Smoothie Cafe chain. While it was founded in Florida, its headquarters has since relocated to Atlanta. Here's what the 10Best writers had to say about it:
"Tropical Smoothie Cafe offers a massive array of beverages that are perfectly designed with your health in mind, with drinks like the Detox Island Green and Chia Banana Boost that provide guests with a double punch of flavor and nutrition that's perfect for starting off your day with a bang. Add to that a selection of health-conscious bowls, salads, and wraps, and you're set."
What are Tropical Smoothie Cafe's best menu items?
"Eat This, Not That!" is a popular healthy eating website. In September, they ranked the healthiest foods and drinks from Tropical Smoothie.
Best bowl: Mixed Berry Greek Yogurt
Best food: Spinach Feta and Pesto Wrap
Best smoothie: Detox Island Green
They also ranked the unhealthiest things you can order from Tropical Smoothie:
Mocha Madness
Buffalo Chicken Wrap
Pomegranate Plunge
Chia Oatmeal Pudding Bowl
How many Tropical Smoothie Cafe locations are in Georgia?
There are 58 Tropical Smoothie Cafes in Georgia, according to ScrapeHero. The full list of Peach State places can be found at locations.tropicalsmoothiecafe.com/ga.
What are the best restaurants for quick, healthy food in US?
Jason's Deli
QDOBA Mexican Eats
El Pollo Loco
Taziki's Mediterranean Cafe
Chipotle Mexican Grill
Cava
Panera Bread
Chick-fil-A
Tropical Smoothie Cafe
Arby's
Miguel Legoas is a Deep South Connect Team Reporter for Gannett/USA Today. Find him on Instagram @miguelegoas and email at mlegoas@gannett.com.
This article originally appeared on Savannah Morning News: USA Today ranks Georgia smoothie chain in 10Best for quick, healthy food
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a few seconds ago
- Yahoo
BioMendics Launches TAMES-02 Clinical Trial for Innovative Epidermolysis Bullosa Simplex Therapy
BioMendics Launches Pivotal TAMES-02 Clinical Trial to Advance TolaSure™ for EB Simplex Patients ROOTSTOWN, Ohio, August 07, 2025--(BUSINESS WIRE)--BioMendics, a clinical-stage biopharmaceutical company focused on rare skin diseases, today announced the launch of the TAMES-02 clinical trial—a multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of TolaSure™, a first-in-class topical therapy for patients with generalized intermediate to severe Epidermolysis Bullosa Simplex (EB Simplex). EB Simplex is a rare, inherited skin disorder that causes painful blistering due to fragile skin, affecting an estimated 30,000 to 50,000 individuals worldwide. With current treatment limited to wound care and infection control, patients and families face a lifelong battle without disease-modifying options. TolaSure, developed by BioMendics, aims to change that reality by targeting the mutant keratins that underlie skin fragility, offering a novel mechanism to reduce blister burden and improve quality of life. The TAMES-02 trial builds on the success of the earlier TAMES-01 study, which demonstrated TolaSure's safety and efficacy in adult patients. Dr. Joyce Teng, Principal Investigator at Stanford University, shared: "Our early studies with TolaSure showed meaningful reduction in blistering, which is incredibly encouraging for the EB Simplex community. Clinical research in rare skin diseases requires collaboration with companies like BioMendics and patient advocacy groups like debra of America to accelerate progress toward transformative therapies. Our shared goal is to bring hope and healing to families who have had so few options for so long." TAMES-02 is being conducted in partnership with Stanford University School of Medicine and Northwestern University Feinberg School of Medicine—two globally recognized leaders in dermatology research. The trial will evaluate TolaSure in patients aged 4 and older and includes a 2-month double-blind, placebo-controlled phase, followed by a 2-month open-label phase where all participants receive TolaSure, and a 6-month follow-up. Importantly, the trial allows patients to treat plantar (foot) blistering—a major source of pain and disability for those living with EB Simplex. Dr. Amy Paller, Principal Investigator at Northwestern University, added: "TAMES-02 is a vital next step. The collaboration with BioMendics and Stanford enables us to rigorously evaluate this therapy and, hopefully, bring real progress to patients who have had limited options for far too long." "We're really excited to be able to cover travel cost to bring patients in from all over the United States and internationally," said Dr. Aleesha McCormick Senior clinical research scientist at BioMendics. "EB Simplex patients don't all live close to an Academic Medical Center like Stanford and Northwestern and our goal is to help as many patients be able to participate in the study as possible. Our study design also lets us recruit slightly less severe patients that may not have flared enough to be eligible for other clinical studies." "Our mission is to bring meaningful therapies to patients living with rare diseases like EB Simplex—conditions that have been overlooked for too long," said Dr. Karen M. McGuire, CEO and Founder of BioMendics. "With TolaSure, we're targeting the root cause of blistering by reinforcing fragile keratinocytes. The TAMES-02 trial is a critical step toward proving safety and efficacy. If successful, we'll seek strategic partnerships to help accelerate development and deliver this treatment to patients as quickly as possible. We also see strong potential for TolaSure in other rare keratin disorders such as pachyonychia congenita and epidermolytic ichthyosis." TAMES-02 reflects BioMendics' ongoing commitment to developing innovative, targeted treatments for rare skin disorders and is currently open for patient enrollment. About BioMendics: For more information about BioMendics please visit our website ( BioMendics is proud to be a REDIzone company at Northeast Ohio Medical University (NEOMED). The REDIzone (Research, Entrepreneurship, Discovery, and Innovation Zone) supports local life science and biomedical entrepreneurs by providing access to NEOMED's resources, expertise, and connections to the region's innovation ecosystem. This partnership has been instrumental in advancing TolaSure from research to clinical development. View source version on Contacts To learn more or inquire about participation, visit or contact the study sites below: Stanford University Dermatology Dr. Joyce Teng (Principal Investigator)Contact: Thomas Buschbacher – tbusch@ Questions about participant rights: 1-866-680-2906 Northwestern University Dermatology Dr. Amy Paller (Principal Investigator)Contact: Dr. Lydia Rabbaa Khabbaz – Questions about participant rights: 312-503-7110 BioMendics, LLC Dr. Karen M. McGuire, CEO & Founder – kmcguire@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNET
2 minutes ago
- CNET
If You're Using ChatGPT for Any of These 11 Things, Stop Right Now
There are a lot of things you can do with ChatGPT, and it seems like that list is getting longer everyday. The powerful LLM chatbot can help you create a budget, plan your meals for the week, reach your health goals and make writing or coding easier. But you don't want to give ChatGPT carte blanche in your life. It's not great at everything -- in fact, it can be downright sketchy at a lot of things. ChatGPT sometimes hallucinates information and passes it off as fact, and it may not always have up-to-date information. It's incredibly confident, even when it's straight up wrong. (The same can be said about other generative AI tools, too, of course.) That matters the higher the stakes get, like when taxes, medical bills, court dates or bank balances enter the chat. If you're unsure about when turning to ChatGPT might be risky, here are 11 scenarios when you should put down the AI and choose another option. Don't use ChatGPT for any of the following. (Disclosure: Ziff Davis, the parent company of CNET, in April filed a lawsuit against ChatGPT maker OpenAI, alleging it infringed Ziff Davis copyrights in training and operating its AI systems.) 1. Diagnosing physical health issues I've definitely fed ChatGPT my symptoms out of curiosity, but the answers that come back can read like your worst nightmare. As you pore over potential diagnoses, you could swing from dehydration and the flu to some type of cancer. I have a lump on my chest and entered that information into ChatGPT. Lo and behold, it told me I may have cancer. In fact, I have a lipoma, which is not cancerous and occurs in 1 in every 1,000 people. My licensed doctor told me that. I'm not saying there are no good uses of ChatGPT for health: It can help you draft questions for your next appointment, translate medical jargon and organize a symptom timeline so you can walk in better prepared. And that could help make doctor visits less overwhelming. However, AI can't order labs or examine you, and it definitely doesn't carry malpractice insurance. Know its limits. 2. Taking care of your mental health ChatGPT can offer grounding techniques, sure, but it can't pick up the phone when you're in real trouble with your mental health. I know some people use ChatGPT as a substitute therapist. CNET's Corin Cesaric found it mildly helpful for working through grief, as long as she kept its limits front of mind. But as someone who has a very real, very human therapist, I can tell you that ChatGPT is still really only a pale imitation at best, and incredibly risky at worst. ChatpGPT doesn't have lived experience, can't read your body language or tone, and has zero capacity for genuine empathy. It can only simulate it. A licensed therapist operates under legal mandates and professional codes that protect you from harm. ChatGPT doesn't. Its advice can misfire, overlook red flags or unintentionally reinforce biases baked into its training data. Leave the deeper work -- the hard, messy, human work -- to an actual human who is trained to properly handle it. If you or someone you love is in crisis, please dial 988 in the US, or your local hotline. 3. Making immediate safety decisions If your carbon-monoxide alarm starts chirping, please don't open ChatGPT and ask it if you're in real danger. I'd go outside first and ask questions later. Large language models can't smell gas, detect smoke or dispatch an emergency crew. In a crisis, every second you spend typing is a second you're not evacuating or dialing 911. ChatGPT can only work with the scraps of info you feed it, and in an emergency, it may be too little and too late. So treat your chatbot as a postincident explainer, never a first responder. 4. Getting personalized financial or tax planning ChatGPT can explain what an ETF is, but it doesn't know your debt-to-income ratio, state tax bracket, filing status, deductions, retirement goals or risk appetite. Because its training data may stop short of the current tax year, and of the latest rate hikes, its guidance may well be stale when you hit enter. I have friends who dump their 1099 totals into ChatGPT for a DIY return. The chatbot simply can't replace a CPA who can catch a hidden deduction worth a few hundred dollars or flag a mistake that could cost you thousands. When real money, filing deadlines, and IRS penalties are on the line, call a professional, not AI. Also, be aware that anything you share with an AI chatbot will probably become part of its training data, and that includes your income, your Social Security number and your bank routing information. 5. Dealing with confidential or regulated data As a tech journalist, I see embargoes land in my inbox every day, but I've never thought about tossing any of these press releases into ChatGPT to get a summary or further explanation. That's because if I did, that text would leave my control and land on a third-party server outside the guardrails of my nondiscloure agreement. The same risk applies to client contracts, medical charts or anything covered by the California Consumer Privacy Act, HIPAA, the GDPR or plain old trade-secret law. It applies to your income taxes, birth certificate, driver's license and passport. Once sensitive information is in the prompt window, you can't guarantee where it's stored, who can review it internally or whether it may be used to train future models. ChatGPT also isn't immune to hackers and security threats. If you wouldn't paste it into a public Slack channel, don't paste it into ChatGPT. 6. Doing anything illegal This one is self-explanatory. 7. Cheating on schoolwork I'd be lying if I said I never cheated on my exams. In high school, I used my first-generation iPod Touch to sneak a peek at a few cumbersome equations I had difficulty memorizing in AP calculus, a stunt I'm not particularly proud of. But with AI, the scale of modern cheating makes that look remarkably tame. Turnitin and similar detectors are getting better at spotting AI-generated prose every semester, and professors can already hear "ChatGPT voice" a mile away (thanks for ruining my beloved em dash). Suspension, expulsion and getting your license revoked are real risks. It's best to use ChatGPT as a study buddy, not a ghostwriter. You're also just cheating yourself out of an education if you have ChatGPT do the work for you. 8. Monitoring information and breaking news Since OpenAI rolled out ChatGPT Search in late 2024 (and opened it to everyone in February 2025), the chatbot can fetch fresh web pages, stock quotes, gas prices, sports scores and other real-time numbers the moment you ask, complete with clickable citations so you can verify the source. However, it won't stream continual updates on its own. Every refresh needs a new prompt, so when speed is critical, live data feeds, official press releases, news sites, push alerts and streaming coverage are still your best bet. 9. Gambling I've actually had luck with ChatGPT and hitting a three-way parlay during the NCAA men's basketball championship, but I would never recommend it to anyone. I've seen ChatGPT hallucinate and provide incorrect information on player statistics, misreported injuries and win-loss records. I only cashed out because I double-checked every claim against real-time odds, and even then I got lucky. ChatGPT can't see tomorrow's box score, so don't rely on it solely to get you that win. 10. Drafting a will or other legally binding contract ChatGPT is great for breaking down basic concepts. If you want to know more about a revocable living trust, ask away. However, the moment you ask it to draft actual legal text, you're rolling the dice. Estate and family-law rules vary by state, and sometimes even by county, so skipping a witness signature or omitting the notarization clause can get your whole document tossed. Rather, let ChatGPT help you build a checklist of questions for your lawyer, then pay that lawyer to turn that checklist into a document that stands up in court. 11. Making art This isn't an objective truth, just my own opinion, but I don't believe AI should be used to create art. I'm not anti-artifical intelligence by any means. I use ChatGPT for brainstorming new ideas and help with my headlines, but that's supplementation, not substitution. By all means, use ChatGPT, but please don't use it to make art that you then pass off as your own. It's kind of gross.
Wall Street Journal
3 minutes ago
- Wall Street Journal
CorMedix to Buy Melinta Therapeutics for $300 Million
CorMedix has signed a deal to buy fellow biopharmaceutical company Melinta Therapeutics from healthcare-focused investment firm Deerfield Management for $300 million in cash and stock. CorMedix on Thursday said the deal adds six marketed infectious-disease products to its offerings, including the antifungal drug Rezzayo, along with the cardiovascular drug Toprol-XL.
